3,4-dihydroxyphenylacetaldehyde has been researched along with rasagiline in 1 studies
| Studies (3,4-dihydroxyphenylacetaldehyde) | Trials (3,4-dihydroxyphenylacetaldehyde) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetaldehyde) | Studies (rasagiline) | Trials (rasagiline) | Recent Studies (post-2010) (rasagiline) |
|---|---|---|---|---|---|
| 99 | 0 | 50 | 535 | 72 | 314 |
| Protein | Taxonomy | 3,4-dihydroxyphenylacetaldehyde (IC50) | rasagiline (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 2.3865 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 1.0029 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.2115 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.088 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.019 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.2217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, WJ; Gillespie, KN; Hsu, FF; Kumar, VB; Lakshmi, VM | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and rasagiline
| Article | Year |
|---|---|
Aldehyde adducts inhibit 3,4-dihydroxyphenylacetaldehyde-induced α-synuclein aggregation and toxicity: Implication for Parkinson neuroprotective therapy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; alpha-Synuclein; Animals; Indans; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Rats | 2019 |